Evaluate Manufacturing Control
Assess whether production, packaging, laboratory and release activities are performed consistently under controlled and documented conditions.
Back to Inspection & Audit
Good Manufacturing Practice Auditing
GMP Audits
Independent, risk-based GMP audits for pharmaceutical, biotechnology, manufacturing, laboratory, packaging and supply-chain organizations seeking stronger product quality, reliable operations, effective quality systems and inspection-ready facilities.
Service Overview
Independent Assurance Across the Manufacturing Lifecycle
GMP audits assess whether facilities, systems, documentation and operational controls consistently support product quality, process reliability and compliance with applicable manufacturing expectations.
Challenge QMS Effectiveness
Review deviations, CAPA, change control, complaints, training, management review and quality oversight for evidence of sustainable control.
Strengthen Third-Party Oversight
Evaluate suppliers, contract manufacturers, laboratories and other critical service providers supporting GMP-regulated activities.
Common GMP Risks
Where Manufacturing and Quality Systems Commonly Lose Control
GMP weaknesses often emerge where documentation, process execution, investigation quality, supplier oversight and management visibility do not operate as one controlled system.
Weak Deviation and CAPA Systems
Investigations do not identify systemic root causes, actions do not address recurrence and effectiveness checks provide limited evidence of risk reduction.
Documentation and Data Integrity Gaps
Batch records, laboratory records, corrections, audit trails or electronic data do not provide complete and reliable evidence of manufacturing activities.
Insufficient Supplier Oversight
Qualification, quality agreements, change notification, performance monitoring and escalation are not consistently managed.
Uncontrolled Process or Facility Risk
Equipment, cleaning, environmental, contamination or maintenance controls do not consistently support reliable production.
GMP Audit Types
Flexible Audit Scope Based on Product and Operational Risk
Audit scope can focus on a facility, system, process, supplier, contract manufacturer or critical compliance concern.
Facility and Manufacturing Audits
Independent assessment of manufacturing operations, facility control, equipment, personnel practices and quality oversight.
- Production and packaging operations
- Facility and equipment controls
- Material and personnel flows
- Cleaning and contamination control
- Documentation and batch execution
Laboratory Audits
Evaluation of laboratory governance, methods, data integrity, equipment, investigations and release-support activities.
- Sample and standard control
- Method execution and validation
- OOS, OOT and atypical result handling
- Laboratory data integrity
- Equipment qualification and calibration
CMO and CDMO Audits
Qualification and oversight audits for contract manufacturing and development organizations supporting regulated products.
- Manufacturing and technical capability
- Quality agreement responsibilities
- Deviation and change notification
- Batch release and communication
- Performance monitoring and governance
Supplier Audits
Independent qualification and oversight of material, component, packaging and critical service suppliers.
- Supplier quality systems
- Material and component controls
- Change notification processes
- Traceability and release controls
- Complaint and CAPA performance
GMP Quality System Audits
Focused assessment of the systems used to govern compliance, investigate problems, manage change and sustain control.
- Deviation and CAPA management
- Change control
- Complaint and recall systems
- Training and document control
- Management review and quality metrics
For-Cause GMP Audits
Focused independent review where recurring failures, serious deviations, data integrity concerns or potential product-quality risk require urgent assessment.
- Recurring deviations and repeat findings
- Data integrity concerns
- Product quality or contamination risk
- Supplier or contractor failure
- Independent investigation support
Audit Scope
Areas Commonly Evaluated During a GMP Audit
The final scope is adapted to the product, facility, manufacturing stage, supply-chain model, known risks and intended business outcome.
Pharmaceutical Quality System
- Management responsibility
- Quality oversight and independence
- Deviation and CAPA systems
- Change control
- Quality metrics and management review
Production and Packaging
- Batch execution
- Line clearance
- Material reconciliation
- In-process control
- Packaging and labeling controls
Facilities and Equipment
- Qualification and maintenance
- Cleaning and sanitation
- Utilities and environmental control
- Calibration and status control
- Contamination prevention
Laboratory Controls
- Sample and standard management
- Method suitability
- OOS and OOT investigations
- Data review and approval
- Electronic record controls
Materials and Suppliers
- Supplier qualification
- Incoming material controls
- Storage and status identification
- Sampling and release
- Supply-chain traceability
Documentation and Data Integrity
- Good documentation practices
- Record corrections and traceability
- Audit trails and access control
- Record retention
- ALCOA+ expectations
Audit Process
A Structured GMP Audit From Planning to Follow-Up
The process is designed to provide objective findings, clear risk classification and practical recommendations for QA, operations and leadership.
Context and Scope Review
Understand the product, facility, process, supplier relationship, previous findings and business purpose of the audit.
Risk-Based Planning
Define audit criteria, documentation needs, sampling strategy, interviewees and high-risk systems requiring deeper assessment.
Pre-Audit Document Review
Review SOPs, quality records, batch documentation, validation files, site information and available performance data.
Audit Execution
Conduct interviews, facility walkthroughs, process observation, document review, record sampling and system demonstrations.
Finding Evaluation
Assess significance, recurrence, systemic impact and potential effect on product quality, patient safety and regulatory compliance.
Reporting and Follow-Up
Deliver risk-ranked findings, recommendations and optional CAPA review or effectiveness verification support.
Deliverables
Clear Outputs for QA, Operations and Leadership
Deliverables can be adapted to supplier qualification, inspection readiness, routine oversight, transaction due diligence or for-cause review.
Audit Plan
- Audit objectives and scope
- Applicable criteria
- Functions and systems included
- Document request list
- Audit schedule and interview plan
Audit Report
- Executive summary
- Evidence-based observations
- Risk classification
- Systemic and recurring themes
- Recommended next steps
Leadership Risk Summary
- Material compliance concerns
- Product-quality implications
- Supplier and oversight risks
- Inspection exposure
- Priority decisions and actions
CAPA Review Support
- Root cause challenge
- Action adequacy review
- Risk reduction assessment
- Evidence expectations
- Closure-readiness considerations
Follow-Up Audit
- CAPA implementation review
- Evidence verification
- Repeat finding assessment
- Residual risk review
- Effectiveness verification
Inspection Readiness Summary
- Critical readiness gaps
- Priority systems and risks
- QA and leadership actions
- Document readiness considerations
- Final readiness priorities
When GMP Audits Are Most Valuable
Common Manufacturing and Supplier Audit Scenarios
GMP audits can support qualification, routine oversight, inspection preparation, due diligence or urgent independent review.
Supplier Qualification
A critical supplier, CMO or laboratory must be assessed before use or contract renewal.
Upcoming GMP Inspection
The organization requires independent assurance over facility, documentation and quality-system readiness.
Recurring Deviations
Repeat failures indicate possible systemic weaknesses in investigation, CAPA or operational control.
Data Integrity Concern
Laboratory, manufacturing or electronic records require focused independent review.
Technology Transfer
New processes, products or manufacturing responsibilities require assurance over readiness and control.
Quality Agreement Review
Responsibilities between sponsor, manufacturer, laboratory or supplier require clarification and stronger governance.
Transaction Due Diligence
A facility, manufacturing platform or acquisition target requires compliance and quality-risk assessment.
For-Cause Investigation
Serious product, process or compliance concerns require confidential independent assurance.
Business Value
Protect Product Quality, Supply Continuity and Regulatory Confidence
Independent GMP audits help organizations identify weaknesses earlier, strengthen manufacturing governance and improve confidence in product, supplier and quality-system control.
Stronger Product Quality Assurance
Identify weaknesses in production, laboratory, documentation and release controls before they create product or patient risk.
More Effective Supplier Oversight
Improve qualification, quality agreement governance, performance monitoring and escalation across the supply chain.
Better Inspection Readiness
Strengthen evidence, process ownership and quality-system visibility before regulatory or client scrutiny.
FAQ
GMP Audit Questions
Common questions from pharmaceutical, biotechnology, manufacturing and supply-chain organizations considering independent GMP audit support.
Can GMP audits be conducted remotely?
Yes. Depending on the scope, documentation, systems and facility access, selected quality-system, supplier, laboratory and document audits can be delivered remotely or through a hybrid model.
Can you audit a contract manufacturer or CDMO?
Yes. Qualification, requalification and oversight audits can be performed for CMOs, CDMOs, contract laboratories and critical service providers.
Can the audit focus on one specific quality system?
Yes. The scope can focus on deviations, CAPA, change control, data integrity, complaints, supplier oversight, laboratory systems or another defined GMP process.
Can you support CAPA development after the audit?
Yes. Support can include root cause review, CAPA adequacy assessment, remediation planning and follow-up effectiveness verification.
Can you conduct confidential for-cause GMP audits?
Yes. For-cause audits can be conducted confidentially when serious product, process, supplier or data-integrity concerns require independent review.
Is NDA-based collaboration available?
Yes. GMP audit engagements are handled confidentially, and NDA-based collaboration can be used where required.